This book is a history of medicines and the commercial actors that make and sell them, covering the 140 years since the modern pharmaceutical industry came into being. It is written in a lively and accessible way, aiming at a general audience that combines historical narrative with fascinating case studies on drug discovery and commercialization, from the rat poison that became warfarin, to a cardiovascular treatment that was turned into Viagra. In a non-partisan way it also examines some of the less noble manifestations of corporate behavior, concluding with an agenda for reform.It is hard to think of anything nobler than to bring to the world a medicine that saves lives. And over 140 years of history, the pharmaceutical industry has produced a range of remarkable products, albeit typically with external scientific and financial support. Making medicines is a very big and profit-driven business, and the industry does not always make the right products for the right people, or at the right prices.The industry wields immense power over lives and economies. How has it risen to this position of dominance? Are the interests of the industry and the public in balance? What should we admire about the industry? What should we criticise and seek to change? The importance of this book lies in the fact that we are all stakeholders in this industry whether or not we own shares, so we all need answers to these questions.Contents: Introduction The Nature of the Pharmaceutical Industry: What is the Pharmaceutical Industry? Regulating Corporate Medicine Antecedents, Origins, and the Emergence of a New Industry: Cells, Germs, Receptors, and Magic Bullets: From Ancient to Modern Theories of the Body, Disease, Drugs, and Drug Action From the Dyeing Arts to Drugs: Or Dye-making, Pharmacy, and the New Research Corporation Science, Business Strategy, and Growth: Making Hormones The Anti-infectives: Sulphonamide, Penicillin, and the Antibiotics Biotechnology, Personalisation, Precision, and the Digital Turn Intellectual Property in Biomedicine The Pharmaceutical Sector and the Public Interest:Prescriptions for a Healthier Pharmaceutical Industry Readership: The educated general public; students and academics in law and medicine (especially business law, regulation, and intellectual property), business studies and economics (especially those interested in pharmaceutical and biotechnology businesses), and various history sub-disciplines (history and philosophy of science, history of medicine, business history); biologists, life scientists, and biotechnologists in public and private sectors; medical practitioners interested in the legal, commercial and social science aspects of their work; and those concerned with access to medicines.
人気のある作家
Napoleon Hill (19) yeoys softback (16) Sourcebooks (15) Italy Editorial DataGroup (13) Japan Editorial DataGroup (13) Robert T. Kiyosaki (13) France Editorial DataGroup (12) Penguin Audio (12) Amy Knapp (11) Brian Tracy (11) mimamour (11) Audible Studios (10) Donte Valenzuela (10) Simon & Schuster Audio (10) Manuela Maier (9) United States Editorial DataGroup (9) Yousuf Hayes (8) Germany Editorial DataGroup (7) Jason Whigham (7) Zackary Horne (7)